Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines
about
Mouse models of dengue virus infection for vaccine testingProtective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus InfectionEndothelial cell dysfunction in viral hemorrhage and edema.Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver DamageUnraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.Selective susceptibility of human skin antigen presenting cells to productive dengue virus infectionOropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells.Characterization of N-Glycan Structures on the Surface of Mature Dengue 2 Virus Derived from Insect Cells.Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesCD8(+) T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection.Endothelial dysfunction in dengue virus pathology.Animal models for dengue vaccine development and testing.A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys.Vaccines licensed and in clinical trials for the prevention of dengue.A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response.Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.Interferon Lambda Genetics and Biology in Regulation of Viral Control.A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus.A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance.Immune Response to Dengue and Zika.Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.Type I interferon receptor knockout mice as models for infection of highly pathogenic viruses with outbreak potential.TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity.Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice
P2860
Q24276139-EDE2F2BC-4B76-45C4-B0AF-4B11CADA991CQ28119679-0537C6F3-AE1F-4864-9784-D4573129AD6AQ33419868-37F911BA-4AAD-4E0C-9532-BF8F9E04BA92Q33425879-30169567-909D-4527-81F6-2EC1E1A58676Q33430984-D691C985-8556-4AA3-94B4-DEC2DD1431B0Q34106393-095C2739-2BFA-458A-AF45-631E05B27AA1Q34495762-F04703F0-81CB-4B24-B540-FF465922DFD6Q34634803-1E8D4716-ED57-4510-B126-1A17EF9BB62BQ35488826-48A9E254-DEC0-47A1-B938-83A160D89D89Q35711415-9F290AC5-719D-499E-8F92-80862A07AC9AQ36569346-14F6D9B2-FB41-4A20-93AA-689296B16F48Q37130999-02A59EC9-585E-4BFD-BE17-31E79D337E6BQ38156594-45E94526-7111-4923-B15B-3FAC6592948AQ38272173-8DFBAB54-4FA7-4613-8F3D-FCFCC0108A89Q38647063-B13B0DDA-5202-4062-A59A-05A8CD695189Q39023333-8B588836-E5F7-4994-8577-00777AD078E6Q39172722-9AB63867-5A3E-4BBF-BD38-C04445CE0462Q39500706-77AE4902-C3F2-4C71-97C9-B3499496461CQ40140549-F2FB18C2-F864-42A1-A7E5-F3EB35DA2C74Q41727151-6040EE88-B082-49D9-B204-A8C4D5AFDB3AQ47141979-7DBA59EC-C5E0-478F-B401-EC988EF53CA9Q47156413-F2CA7C55-FBE1-45D9-8C2B-C11EC6C02D92Q47194469-4F64DDF5-9AF0-4642-8737-8751D77FEBE1Q47371006-043AEE7C-8936-4F31-9140-EA56EC7DF0E1Q47551925-2BF121F7-3AF2-4BDE-9D02-9C4E4B8B2FA7Q51336680-A937569D-3279-44CF-8A90-D72FB1D37790Q51784327-716396B1-963B-4560-BC01-C395F4804D01Q52645929-3471622E-A3DC-4454-80A1-5098B16A3E9BQ56797663-4E94537E-6548-4B24-819B-B752F9BC070C
P2860
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Type I interferon signals in m ...... model to test dengue vaccines
@ast
Type I interferon signals in m ...... model to test dengue vaccines
@en
type
label
Type I interferon signals in m ...... model to test dengue vaccines
@ast
Type I interferon signals in m ...... model to test dengue vaccines
@en
prefLabel
Type I interferon signals in m ...... model to test dengue vaccines
@ast
Type I interferon signals in m ...... model to test dengue vaccines
@en
P2093
P2860
P50
P356
P1433
P1476
Type I interferon signals in m ...... model to test dengue vaccines
@en
P2093
Ernesto Marcos
Gerardo Guillén
Iris Valdés
Julia Heinrich
Katja Fink
Lisset Hermida
Ying-Xiu Toh
P2860
P304
P356
10.1128/JVI.03827-13
P577
2014-04-16T00:00:00Z